pfizer glp-1 pipeline Acquires Metsera for $4.9 B, Boosts Obesity | Jayaprakash Kolla posted on the topic Pfizer vs Novo Nordisk: Obesity

Understand the place in therapy of GLP-1 and GIP analogues for glycaemic control in type 2 diabetes mellitus

East Asia Market Insight : East Asia is increasingly focused on metabolic health and weight loss, with a growing interest in GLP-1 boosters as part of a comprehensive health regimen

& Plckthun, A

GLP-1 Lozenges start at $199 per month as daily dissolvable lozenges, providing another needle-free alternative

I think we will see potential watershed deals of really significant transactions that focus more on the data ecosystem, AI and digital health aspects in the market

Curb cravings and support a healthy metabolism with Akkermansia, a GLP-1 boosting probiotic to promote a healthy digestive system